Coexpression and interaction of CXCL10 and CD26 in mesenchymal cells by synergising inflammatory cytokines: CXCL8 and CXCL10 are discriminative markers for autoimmune arthropathies

Arthritis Research and Therapy

Volumn 8, Issue 4, 2006, Pages

  Proost, Paul ^a   Struyf, Sofie ^a   Loos, Tamara ^a   Gouwy, Mieke ^a   Schutyser, Evemie ^a   Conings, René ^a   Ronsse, Isabelle ^a   Parmentier, Marc ^b   Grillet, Bernard ^a,c   Opdenakker, Ghislain ^a   Balzarini, Jan ^a   Van Damme, Jo ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^c Ziekenhuis Zeeuws Vlaanderen   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CHEMOKINE; AUTACOID; BIOLOGICAL MARKER; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CXCR3; CXCL10 PROTEIN, HUMAN; CXCR3 PROTEIN, HUMAN; CYTOKINE; DIPEPTIDYL PEPTIDASE IV; DRUG COMBINATION; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 8; ISOPROTEIN; LIGAND; PEPTIDE FRAGMENT;

ARTHROPATHY; AUTOIMMUNE DISEASE; CELL CULTURE; CHEMISTRY; COMPARATIVE STUDY; DERMIS; DRUG COMBINATION; ENDOTHELIUM CELL; FIBROBLAST; HUMAN; METABOLISM; NEWBORN; RHEUMATIC DISEASE; SIGNAL TRANSDUCTION; VASCULARIZATION;

AUTOIMMUNE DISEASES; BIOLOGICAL MARKERS; CELLS, CULTURED; CHEMOKINE CXCL10; CHEMOKINES, CXC; CYTOKINES; DERMIS; DIPEPTIDYL PEPTIDASE 4; DRUG COMBINATIONS; ENDOTHELIAL CELLS; FIBROBLASTS; HUMANS; INFANT, NEWBORN; INFLAMMATION MEDIATORS; INTERLEUKIN-8; JOINT DISEASES; LIGANDS; PEPTIDE FRAGMENTS; PROTEIN ISOFORMS; RECEPTORS, CHEMOKINE; RECEPTORS, CXCR3; RHEUMATIC DISEASES; SIGNAL TRANSDUCTION;

EID: 34250208691     PISSN: 14786354     EISSN: 14786362     Source Type: None    
DOI: 10.1186/ar1997     Document Type: Article

References (45)

1. Zlotnik AA Yoshie O: Chemokines: a new classification system and their role in immunity. Immunity 2000, 12:121-127.
2. Rot A, von Andrian UH: Chemokines in innate and adaptive host defense: Basic chemokinese grammar for immune cells. Annu Rev Immunol 2004, 22:891-928.
3. Moser B, Molf M, Walz A, Loetscher P: Chemokines: multiple levels of leukocyte migration control. Trends Immunol 2004, 25 75-84.
4. Murphy PM: International Union of Pharmacology. XXX. Update on chemokine receptor nomenclature. Pharmacol Rev 2002, 54 227-229.
5. Van Damme J, Proost P, Put W, Arens S, Lenaerts JP, Conings R, Opdenakker G, Heremans H, Billiau A: Induction of monocyte chemotactic proteins MCP-1 and MCP-2 in human fibroblasts and leukocytes by cytokines and cytokine inducers. Chemical synthesis of MCP-2 and development of a specific RIA. J Immunol 1994, 152 5495-5502.
6. Strieter RM, Phan SH, Showell HJ, Remick DG, Lynch JP, Genord M, Raiford C, Eskandari M, Marks RM, Kunkel SL: Monokine-induced neutrophil chemotactic factor gene expression in human fibroblasts. J Biol Chem 1989, 264:10621-10626.
7. Tensen CP, Flier J, Van Der Raaij-Helmer EM, Sampat-Sardjoepersad S, Van Der Schors RC, Leurs R, Scheper RJ, Boorsma DM, Willemze R: Human IP-9: A keratinocyte-derived high affinity CXC-chemokine ligand for the IP-10/Mig receptor (CXCR3). J Invest Dermatol 1999, 112 716-722.
8. FarbAr JM: HuMig: a new human member of the chemokine family of cytokines. Biochem Biophys Res Commun 1993, 192:223-230.
9. Luster AD, Unkeless JC, Ravetch JV: Gamma-interferon transcriptionally regulates an early-response gene containing homology to platelet proteins. Nature 1985, 315:672-676.
10. Cole KE, Strick CA, Paradis TJ, Ogborne KT, Loetscher M, Gladue RP, Lin W, Boyd JG, Moser B, Wood DE, et al.: Interferon-inducible T cell alpha chemoattractant (I-TAC): A novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3. J Exp Med 1998, 187:2009-2021.
11. Proost P, Vynckier AK, Mahieu F, Put W, Grillet B, Struyf S, Wuyts A, Opdenakker G, Van Damme J: Microbial Toll-like receptor ligands differentially regulate CXCL10/IP-10 expression in fibroblasts and mononuclear leukocytes in synergy with IFN-γ and provide a mechanism for enhanced synovial chemokine levels in septic arthritis. Eur J Immunol 2003, 33:3146-3153.
12. Proost P, Verpoest S, Van de Borne K, Schutyser E, Struyf S, Put W, Ronsse I, Grillet B, Opdenakker G, Van Damme J: Synergistic induction of CXCL9 and CXCL11 by Toll-like receptor ligands and interferon-γ in fibroblasts correlates with elevated levels of CXCR3 ligands in septic arthritis synovial fluids. J Leukoc Biol 2004, 75:777-784.
13. Cassatella MA, Gasperini S, Calzetti F, Bertagnin A, Luster AD, McDonald PP: Regulated production of the interferon-γ-inducible protein-10 (IP-10) chemokine by human neutrophils. Eur J Immunol 1997, 27:111-115.
14. Gasperini S, Marchi M, Calzetti F, Laudanna C, Vicentini L, Olsen H, Murphy M, Liao F, Farber J, Cassatella MA: Gene expression and production of the monokine induced by IFN-γ (MIG), IFNinducible T cell α chemoattractant (I-TAC), and IFN-γ-inducible protein-10 (IP-10) chemokines by human neutrophils. J Immunol 1999, 162 4928-4937.
15. Ohmori Y, Schreiber RD, Hamilton TA: Synergy between interferon-γ and tumor necrosis factor-α in transcriptional activation is mediated by cooperation between signal transducer and activator of transcription 1 and nuclear factor κB. J Biol Chem 1997, 272 14899-14907.
16. Romagnani P, Lazzeri E, Lasagni L, Mavilia C, Beltrame C, Francalanci M, Rotondi M, Annunziato F, Maurenzig L, Cosmi L, et al.: IP-10 and Mig production by glomerular cells in human proliferative glomerulonephritis and regulation by nitric oxide. J Am Soc Nephrol 2002, 13:53-64.
17. Gouwy M, Struyf S, Proost P, Van Damme J: Synergy in cytokine and chemokine networks amplifies the inflammatory response. Cytokine Growth Factor Rev 2005, 16:561-580.
18. Lee TH, Lee GW, Ziff EB, Vilcek J: Isolation and characterization of eight tumor necrosis factor-induced gene sequences from human fibroblasts. Mol Cell Biol 1990, 10:1982-1988.
19. Opdenakker G, Van den Steen PE, Dubois B, Nelissen I, Van Coillie E, Masure S, Proost P, Van Damme J: Gelatinase B functions as regulator and effector in leukocyte biology. J Leukoc Biol 2001, 69 851-859.
20. Sorrell JM, Brinon L, Baber MA, Caplan AI: Cytokines and glucocorticoids differentially regulate APN/CD13 and DPP IV/CD26 enzyme activities in cultured human dermal fibroblasts. Arch Dermatol Res 2003, 295:160-168.
21. Nemoto E, Sugawara S, Takada H, Shoji S, Horiuch H: Increase of CD26/ dipeptidyl peptidase IV expression on human gingival fibroblasts upon stimulation with cytokines and bacterial components. Infect Immun 1999, 67:6225-6233.
22. Proost P, Schutyser E, Menten P, Struyf S, Wuyts A, Opdenakker G, Detheux M, Parmentier M, Durinx C, Lambeir AM, et al.: Aminoterminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties Blood 2001, 98:3554-3561.
23. Elliott MJ, Maini RN, Feldmann M, Long-Fox A, Charles P, Bijl H, Woody JN: Repeated therapy with monoclonal antibody to tumour necrosis factor a (cA2) in patients with rheumatoid arthritis. Lancet 1994, 344:1125-1127.
24. Schiff MH: Durability and rapidity of response to anakinra in patients with rheumatoid arthritis. Drugs 2004, 64 2493-2501.
25. Sedo A, Duke-Cohan JS, Balaziova E, Sedova LR: Dipeptidyl peptidase IV activity and/or structure homologs: Contributing factors in the pathogenesis of rheumatoid arthritis? Arthritis Res Ther 2005, 7:253-269.
26. Qin S, Rottman JB, Myers P, Kassam N, Weinblatt M, Loetscher M, Koch AE, Moser B, Mackay CR: The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J Clin Invest 1998, 101:746-754.
27. Bathon JM, Proud D, Mizutani S, Ward PE: Cultured human synovial fibroblasts rapidly metabolize kinins and neuropeptides. J Clin Invest 1992, 90:981-991.
28. Proost P, De Wolf-Peeters C, Conings R, Opdenakker G, Billiau A, Van Damme J: Identification of a novel granulocyte chemotactic protein (GCP-2) from human tumor cells. In vitro and in vivo comparison with natural forms of GRO, IP-10, and IL-8. J Immunol 1993, 150:1000-1010.
29. Van Damme J, Decock B, Conings R, Lenaerts JP, Opdenakker G, Billiau A: The chemotactic activity for granulocytes produced by virally infected fibroblasts is identical to monocyte-derived interleukin 8. Eur J Immunol 1989, 19:1189-1194.
30. Scharpé S, De Meester I, Vanhoof G, Hendriks D, van Sande M, Van Camp K, Yaron A: Assay of dipeptidyl peptidase IV in serum by fluorometry of 4-methoxy-2-naphthylamine. Clin Chem 1988, 34 2299-2301.
31. Gorrell MD: Dipeptidyl peptidase IV and related enzymes in cell biology and liver disorders. Clin Sci (Lond) 2005, 108 277-292.
32. Durinx C, Lambeir AM, Bosmans E, Falmagne JB, Berghmans R, Haemers A, Scharpé S, De Meester I: Molecular characterization of dipeptidyl peptidase activity in serum: Soluble CD26/dipeptidyl peptidase IV is responsible for the release of X-Pro dipeptides. Eur J Biochem 2000, 267:5608-5613.
33. Luster AD: The role of chemokines in linking innate and adaptive immunity. Curr Opin Immunol 2002, 14:129-135.
34. Van Damme J, De Ley M, Van Snick J, Dinarello CA, Billiau A: The role of interferon-β1 and the 26-kDa protein (interferon-β2) as mediators of the antiviral effect of interleukin 1 and tumor necrosis factor. J Immunol 1987, 139:1867-1872.
35. Struyf S, Proost P, Van Damme J: Regulation of the immune response by the interaction of chemokines and proteases. Adv Immunol 2003, 81:1-44.
36. Hebert CA, Luscinskas FW, Kiely JM, Luis EA, Darbonne WC, Bennett GL, Liu CC, Obin MS, Gimbrone MA Jr, Baker JB: Endothelial and leukocyte forms of IL-8. Conversion by thrombin and interactions with neutrophils J Immunol 1990, 145:3033-3040.
37. Nakagawa H, Hatakeyama S, Ikesue A, Miyai H: Generation of interleukin-8 by plasmin from AVLPR-interleukin-8, the human fibroblast-derived neutrophil chemotactic factor. FEBS Lett 1991, 282:412-414.
38. Sica A, Matsushima K, Van Damme J, Wang JM, Polentarutti N, Dejana E, Colotta F, Mantovani A: IL-1 transcriptionally activates the neutrophil chemotactic factor/IL-8 gene in endothelial cells. Immunology 1990, 69:548-553.
39. Smit MJ, Verdijk P, Van Der Raaij-Helmer EM, Navis M, Hensbergen PJ, Leurs R, Tensen CP: CXCR3-mediated chemotaxis of human T cells is regulated by a Gi- and phospholipase Cdependent pathway and not via activation of MEK/p44/p42 MAPK nor Akt/PI-3 kinase. Blood 2003, 102:1959-1965.
40. Hensbergen PJ, Verzijl D, Balog CI, Dijkman R, Van Der Schors RC, Van Der Raaij-Helmer EM, van der Plas MJ, Leurs R, Deelder AM, Smit MJ, et al.: Furin is a chemokiIe-modifying enzyme: in vitro and in vivo processing of CXCL10 generates a C-terminally truncated chemokine retaining full activity. J Biol Chem 2004, 279 13402-13411.
41. Busso N, Wagtmann N, Herling C, Chobaz-Peclat V, Bischof-Delaloye A, So A, Grouzmann E: Circulating CD26 is negatively associated with inflammation in human and experimental arthritis. Am J Pathol 2005, 166:433-442.
42. McGonagle D, Gibbon W, Emery P: Classification of inflammatory arthritis by enthesitis. Lancet 1998, 352:1137-1140.
43. Matthys P, Lories RJ, De Klerck B, Heremans H, Luyten FP, Billiau A: Dependence on interferon-? for the spontaneous occurrence of arthritis in DBA/1 mice. Arthritis Rheum 2003, 48:2983-2988.
44. Lambeir AM, Durinx C, Scharpé S, De Meester I: Dipeptidyl-peptidase IV from bench to bedside: An update on structural properties, functions, and clinical aspects of the enzyme DPP IV. Crit Rev Clin Lab Sci 2003, 40:209-294.
45. Pascual V, Allantaz F, Arce E, Punaro M, Banchereau J: Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade. J Exp Med 2005, 201:1479-1486.